WASHINGTON --- As a major free trade agreement nears the end of negotiations, the United States appears to be doubling down and even strengthening its demands for restrictive new provisions that public health advocates warn would significantly curtail access to affordable medicines and health care in developing countries. Internal documents
Secretive US Trade Deal Could Endanger Global Health Gains
Much of the concern focuses on a host of provisions that would impact the ability of poor communities to get cheap generic medicines.